通过CRISPR/Cas9介导的Fel d1的CH2删除触发了猫细胞中的转录基因重编程和与疾病相关的途径
Lin-Yi Qu1, Fu-Shi Quan1, Shu-Ming Shi1
1College of Animal Sciences, Jilin University, Changchun, Jilin, China.
Frontiers in cell and developmental biology
|December 8, 2025
概括
基因编辑Fel d1,主要的猫类过敏原,成功降低了过敏原水平,但导致了意外的基因表达变化. 在培养低过敏性猫之前,全面的安全评估至关重要.
科学领域:
- 遗传学和分子生物学
- 过敏学 过敏学
- 动物生物技术动物生物技术
背景情况:
- Fel d1是主要的猫类过敏原,在人类中引起过敏反应.
- Fel d1 的生理作用在很大程度上是未知的.
- 培养低过敏性猫是过敏患者的一个重要目标.
研究的目的:
- 通过敲除其CH2域来研究Fel d1的功能.
- 评估使用基因编辑生产低过敏性猫的可行性.
- 评估Fel d1基因淘汰的安全性和潜在副作用.
主要方法:
- 使用CRISPR/Cas9基因编辑,在猫皮肤细胞中敲除Fel d1的CH2域.
- 绝杀效率通过测序,qRT-PCR和西部涂抹得到证实.
- 使用RNA-seq,GO,KEGG和GSEA分析了转录组变化,使用CCK-8,EDU和流细胞计进行了表型评估.
主要成果:
- 成功生成了一个框架转移突变,导致Fel d1 mRNA和蛋白质几乎完全丧失.
- RNA-seq揭示了3,469个差异表达的基因,其中丰富的基因存在于多变性心肌病和类风湿性关节炎的途径中.
- 缺失CH2损害了细胞增殖和亡的增加,并对TGFB2,MYBPC3,MMP3和TLR4等关键基因进行上调.
结论:
- 虽然CH2域删除有效地消除了主要的猫类过敏原Fel d1,但它会诱导显著的转录基因重编程.
- 这些意想不到的变化与病理状态有关,突出显示了潜在的安全问题.
- 在利用基因编辑细胞用于低过敏性猫的发育之前,包括转录组学在内的全面安全分析至关重要.
更多相关视频
08:14Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
12.9K
10:21Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
Published on: January 5, 2018
13.6K
相关概念视频
CRISPR
57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
CRISPR/Cas9 Genome Editing
1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K
